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ABSTRACT
Objective: Obesity is a major public health issue and a significant risk factor for metabolic disorders. This prospective study was aimed at evaluating 
the prevalence of obesity, lipid profiles, and fasting blood glucose (FBG) among female premedical students of NAU, Nnewi Campus, Nigeria.
Methods: A total of 320 female premedical students aged 18–35 years were recruited. The participants were classified using Body mass index(BMI)
as underweight (35), overweight (104), obese (26), and control (155). FBG and lipids were estimated using enzymatic methods. Obesity was assessed 
using BMI and waist circumference. Blood pressure (BP) was measured using accoson sphygmomanometer.
Results: The study observed 10.9% underweight, 32.5% overweight, and 8.1% obesity. Underweight was higher among participants aged 18–23 years 
(48.6%), while overweight and obesity were more among participants aged 24–29 years (57.7% and 53.8%). Central obesity was observed in 28.8% 
of participants. BPs were higher in obese and overweight participants than in other groups. FBG was higher in obese and overweight participants than 
in other groups. The mean total cholesterol (TC) and low-density lipoprotein cholesterol (LDLC) were significantly higher in obese and overweight 
participants, while high-density lipoprotein cholesterol (HDLC) was significantly lower when compared to their corresponding values in underweight 
and control participants (p<0.05).
Conclusions: The study showed high prevalence of underweight, overweight, and obesity among the study population. The significantly higher levels 
of TC, LDLC, FBG, and elevated BP with significantly lower HDLC in overweight and obese participants compared to control suggests a possible risk 
of dyslipidemia, diabetes mellitus, and hypertension. The significant correlation between the lipid parameters, FBG, and anthropometric indices 
suggests high-risk cardiovascular disorders.
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INTRODUCTION
Obesity is a major non-communicable disease which has become a public 
health issue and future menace in developing countries, Nigeria inclusive. 
Young adult students of tertiary institutions are not left out. People are 
generally considered obese when their body mass index (BMI) is over 
30 kg/m2, with the range 25–30 kg/m2 defined as overweight. This is 
determined by dividing a person’s weight by the square of the person’s 
height (kg/m2) [1]. It has been estimated that more than 1 billion adults 
are overweight globally with more women being commonly obese than 
men [1]. About 300 million of them are clinically obese. This contributes 
enormously to the global burden of chronic disease and disability. Obesity is 
a very complex condition and mostly occurs together with undernutrition 
with serious social and psychological dimensions, affecting virtually all 
ages and socioeconomic groups in developing countries [2]. Excessive 
consumption of more energy dense and poor nutritional foods with high 
levels of sugar and saturated fats and reduced physical activity including 
genetic disorders has led to obesity [1,3]. Other minor causes of obesity 
are genes, medications, endocrine abnormality, and mental problem [4]. 
Previous study has classified obesity as a disease [5]. Obesity epidemic is 
not restricted to industrialized countries only but greatly multiplies faster 
in developing countries than in the developed world [2].
However, obesity and overweight are associated with major 
risk for chronic diseases, including type 2 diabetes mellitus and 
lipid peroxidation, hypertension, and atherosclerosis. The health 
implications of these include increased risk of morbidity and 
mortality such as premature death [2,6,7]. In developed countries, the 
incidence of obesity was reported to correspond to the widespread 
of diabetes [8]. The frequency of abnormality of lipids, lipoproteins, 
and apolipoproteins varies in different populations. Lipoprotein 
abnormalities often precede the onset of diabetes mellitus by many 
years and persist despite achievement of euglycemia, possibly as a 
result of increased rates of obesity [8,9]. Lipoprotein abnormalities 
are common in diabetes and contribute significantly to its 
complications. The most typical lipoprotein pattern in diabetes, also 
known as diabetic dyslipidemia or atherogenic dyslipidemia, consists 
of moderate elevation in triglyceride (TG) levels, low high-density 
lipoprotein cholesterol (HDLC) values, and small dense low-density 
lipoprotein (LDL) particles [9]. The present study, therefore, seeks 
to evaluate the prevalence of obesity and assess the lipid profile 
and fasting blood glucose (FBG) among the undergraduate female 
premedical students of Nnamdi Azikiwe University, Nnewi Campus, 
Nigeria.
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METHODS
Study design
This was a cross-sectional study designed to evaluate the prevalence of 
obesity and assess the FBG level and fasting lipid profile among female 
undergraduate pre-medical students of the College of Health Sciences, 
Nnamdi Azikiwe University, Nnewi Campus, Nnewi, Nigeria. The 
demographic data and medical history were clinically obtained using 
pre-administered questionnaire. Blood glucose levels and lipid profile 
were obtained after overnight fasting (12–14 h).
Study population
A total of 320 undergraduate students aged between 18 and 35 years 
were recruited for this study using simple random sampling technique. 
They were categorized using their BMI as underweight (35), overweight 
(104), and obese (26) participants. The remaining 155 participants 
were normal (control) participants.
Data collection
A well-structured questionnaire was administered to all the participants 
to ascertain their medical history. The height and weight of the subjects 
were measured. Height was measured to the nearest 0.1 cm using a 
tape rule, and weight measured to the nearest 0.1 kg using calibrated 
platform scales. The body mass index (BMI) was calculated by the 
formula of weight (kg)/height (m2).Obesity was assessed using body 
mass index (BMI) and waist circumference (WC). Based on BMI, the 
participants were categorized as underweight (<18.5 kg/m2), normal 
weight (18.5–24.9 kg/m2), overweight (25.0–29.9kg/m2), and obese 
(>30.0 kg2) [10]. WC was measured midway between iliac crest and 
coastal margin. WC cutoff value of >80 cm is regarded as risk factor 
for obesity in females. Three separate blood pressure (BP) readings 
were obtained per subject from the non-dominant arm using accoson 
sphygmomanometer with appropriate cuff size in sitting position at 
2 min interval after an initial rest of 5–10 min with arm supported at 
heart level. The average of the past two readings was recorded for both 
systolic blood pressure and diastolic blood pressures (SBP and DBP) 
of each student. The cutoff value for hypertension was taken as SBP 
reading ≥130 mmHg and/or DBP of ≥85 mmHg.
Collection of sample
Random sampling technique was used during sample collection. 
Of 7 ml of venous blood collected, 5 ml was dispensed into plain 
specimen container and allowed to retract, centrifuged and separated 
for the determination of fasting lipid profile, while remaining 2 ml 
was dispensed into fluoride oxalate specimen container for FBG level 
estimation.
Exclusion and inclusion criteria
Students within the age range of 18–35 years were included in the 
study. Students who were pregnant, smokers, non-students, students 
above the age 35, known diabetics, and students with any known form 
of cardiovascular condition were excluded from the study.
Ethics approval and consent to participate
All authors hereby declare that all experiment and procedure have 
been examined and approved by the appropriate board of the Ethics 
Committee of Nnamdi Azikiwe University Teaching Hospital Nnewi, 
South East Nigeria, and research have therefore been performed in 
accordance with the standards laid down in the 1964 Declaration of 
Helsinki.
Laboratory methods of sample analysis
Fasting lipid profile test (total cholesterol [TC], TG, HDLC, and 
LDL cholesterol [LDLC])
TC was determined as described by Trinder [11], while TGs was 
determined using the method by Tietz [12]. The estimation of HDL was 
performed using the method as described by Groove [13] and Burstein 
et al. [14]. This is principally a combination of phosphotungstate 
precipitation and enzymatic method, while the method of Assman 
et al. [15] was adopted for LDL. This is a combination of polyvinyl 
sulfate precipitation and enzymatic method.
FBG estimation
Glucose oxidase method was used to measure FBG 
spectrophotometrically as described by Julio and Montola [16].
Statistical analysis
Statistical analysis was performed using Statistical Package for the 
Social Sciences version 20. The test of significant difference between 
the two groups was calculated using the student’s t-test with p<0.05. 
Pearson’s correlation coefficient was used to determine the relationship 
between the lipid profile, FBG, and anthropometric indices.
RESULTS
Demographic characteristics of study population
The results showed that of 320 female premedical students recruited for 
the study, 35 (10.9%) were underweight, 104 (32.5%) were overweight, 
26 (8.1%) were obese, while 155 (48.4%) were normal participants. 
The prevalent rate of underweight was higher among participants aged 
18–23 years (17, 48.6%). Overweight and obesity were more among the 
age range of 24–29 years of 60 (57.7%) and 14 (53.8%) participants, 
respectively. The WC of overweight and obese participants who were at 
risk of central obesity was 30 (28.8%) and 8 (30.8%), respectively. They 
had elevated WC of over 80 cm. 35 (33.7%) overweight and 9 (34.6%) 
obese participants had higher SBP, while 30 (28.8%) overweight and 
10 (38.5%) obese participants had higher DBP. 10 (28.6%) underweight 
participants had lower FBG, while 32 (30.8%) overweight and 4 (15.4%) 
obese participants had higher FBG levels (Table 1).
Comparison (BMI [kg/m2], WC [cm], SBP [mmHg], DBP [mmHg], 
and age) in underweight, overweight, obese, and non-obese 
(control) female students
The mean BMI in underweight (18.01±0.34) and overweight 
(26.81±0.87) female students was significantly lower compared to 
obese subjects (35.69±1.94) (p<0.05). BMI was significantly higher in 
overweight (26.81±0.87 and obese (35.69±1.94) females compared 
with their corresponding control (22.34±1.71) (p<0.05). Similar 
observation was made between underweight (18.01±0.34) and control 
(22.34±1.71) female students. The mean WC was significantly higher 
in overweight (82.34±7.68) and obese (87.08±8.91) compared with 
underweight (72.01±0.23) and control (72.01±0.23) counterparts 
(p<0.05 respectively). Similarly, WC was significantly higher in obese 
(87.08±8.91) compared with the overweight (82.34±7.68) female 
students (p<0.05). The value of SBP in overweight (132.22±11.20) 
and obese (136.48±14.12) female students was significantly higher 
compared with the value in control females (115.56±8.56) (p<0.05, 
respectively), while the value of DBP in overweight (83.76±8.45) 
and obese female students (87.89±11.45) was significantly higher 
when compared with the value in control (66.83±7.60) counterparts 
(p<0.05). However, there was no significant difference in the mean age 
difference of underweight (25.10±4.87), overweight (24.88±6.2), and 
obese (25.10±5.34) female premedical students when compared with 
control counterparts (24.94±3.35) (p>0.05, respectively) (Table 2).
Lipid profile (mmol/l) and FBG (mmol/l) levels in underweight, 
overweight, obese, and control female students
The mean TC level in overweight (5.28±0.86) and obese (5.86±0.92) 
was significantly higher compared with control (4.41±0.84) female 
students (p<0.05, respectively). No significant difference was observed 
in the value of TC between underweight (4.05±0.25) and control 
(4.41±0.84) female students (p<0.05).
However, the mean HDLC in overweight (1.07±0.29) and obese 
(0.89±0.17) female students was significantly lower compared with 
underweight (1.46±0.43) and control (1.44±0.56) counterparts (p<0.05 
respectively). No significant difference was observed in HDL level 
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between underweight (1.46±0.43) and control (1.44±0.56) females 
(p>0.05) and between overweight (1.07±0.29) and obese (0.89±0.17) 
counterparts (p>0.05).
LDLC level in overweight (3.46±0.58) and obese (4.26±0.84) female 
students was significantly higher compared with their corresponding 
values in underweight (3.01±0.31) and control (3.18±0.49) females 
(p<0.05, respectively). No significant difference existed between 
underweight (3.01±0.31) and control (3.18±0.49) females (p>0.05). 
Contrastingly, the mean LDLC level was significantly lower in overweight 
(3.46±0.58) compared obese (4.26±0.84) female students (p<0.05).
The mean TG level in underweight (1.11±0.45), overweight (1.21±0.64), 
and obese (1.25±0.84) female students was not significantly different 
from control (1.19±0.39) counterparts (p>0.05, respectively).
The mean FBG level in overweight (5.01±0.29) and obese (5.12±0.38) 
was significantly higher compared with the values in underweight 
(4.72±0.36) and control (4.83±0.32) female students (p<0.05). On the 
other hand, no significant difference was existed between underweight 
(4.72±0.36) and control (4.83±0.32) female students (p>0.05) (Table 3).
Pearson correlation of lipid profile (mmol/l), FBG (mmol/l), and 
anthropometric parameters in overweight and obese participants
Significant positive correlation was observed between TC and age, 
FBG; TG and age, FBG, WC; LDL and FBS; HDL and age while significant 
negative correlation existed between TC and BMI, SBP, DBP; TG and 
BMI; HDL and BMI, WC in both overweight and obese participants.
DISCUSSION
The present study recorded 10.9% underweight, 32.5% overweight, 
and 8.1% obesity among all the study population. Underweight was 
more common among students whose age ranged 18–23 years. The 
high incidence of underweight among university students has been 
previously reported [17,18]. The overall implications of this include 
malnutrition, menstrual irregularities, diabetes, osteoporosis, and 
reduced immunity [19-21]. The prevalence of underweight recorded 
among these students may be attributed not only to poor feeding 
habits but also to misperceptions usually exhibited by these female 
students that they want to maintain a good shape. Most of the students 
under this age range might be newly admitted students who have not 
become acquainted with university environment and their feeding 
habits [17,22-25]. The overweight and obesity were more prevalent 
in female premedical undergraduate students between the age 
range of 24 and 29 years although overweight was higher than obese 
participants. This is in agreement with study by Oguoma et al. [21,26]. 
Similarly, SBP, DBP, WC, and FBG were all elevated in overweight and 
obese students when compared with control participants. These 
findings indicate that the overweight students were at the verge of 
getting to obesity, central obesity, hypertension, and pre-diabetes 
which might result to future cardiovascular diseases if the risk factors 
Table 1: Demographic characteristics of the study population
BMI parameters Underweight (<18.5) F % 
n=35, 10.9
Overweight (25–29.9) F % 
n=104, 32.5
Obese (>30) F % 
n=26, 8.1
Normotensive (18.5–24.9) F % 
n=155, 48.4
Age
18–23 17 (48.6) 25 (24.2) 8 (19.2) 79 (50.9)
24–29 12 (34.3) 60 (57.7) 14 (58.8) 40 (25.8)
30–34 6 (17.1) 19 (18.3) 7 (26.9) 36 (23.2)
WC
Normal 35 (100) 74 (71.2) 18 (69.2) 135 (87.1)
At risk 0 (0) 30 (28.8) 8 (30.8) 20 (12.9)
SBP
Normal 33 (94.3) 55 (52.9) 16 (61.5) 146 (94.2)
Low 1 (2.8) 14 (13.5) 1 (3.8) 1 (0.6)
High 1 (2.8) 35 (33.7) 9 (34.6) 8 (5.2)
DBP
Normal 35 (100) 62 (59.6) 14 (53.8) 151 (97.4)
Low 0 (0) 12 (11.5) 2 (7.7) 1 (0.06)
High 0 (0) 30 (28.8) 10 (38.5) 3 (1.9)
FBG
Normal 25 (71.4) 70 (67.3) 22 (84.6) 140 (90.3)
Low 10 (28.6) 2 (1.9) 0 (0) 13 (8.4)
High 0 (0) 32 (30.8) 4 (15.4) 2 (1.3)
BMI: Basal metabolic index, F: Frequency, %: Percentage, n: Number. FBG: Fasting blood glucose, WC: Waist circumference, SBP: Systolic blood pressure, DBP: Diastolic 
blood pressures
Table 2: Comparison of mean (±SD) BMI (kg/m2), WC (cm), SBP, DBP, and age in underweight, overweight, obese, and 
normotensive (control) female premedical students
Groups BMI WC SBP DBP Age
Underweight (A)(n=30) 18.01±0.S34 72.01±0.23 101.28±9.94 68.24±6.76 25.01±4.87
Overweight (B) (n=104) 26.81±0.87 82.34±7.68 132.12±11.20 83.76±8.45 24.88±6.20
Obese (C) (n=31) 35.69±1.94 87.08±8.91 136.48±14.12 87.89±11.45 25.10±5.34
Normotensive (D) (n=155) 22.34±1.71 76.59±2.74 115.56±8.56 66.83±7.60 24.94±3.35
F-value 4.194 −4.620 36.194 32.839 0.062
p-value 0.000 0.000 0.000 0.013 0.912 
A vs. B 0.000 0.001 0.093 0.006 0.741
A vs. C 0.000 0.000 0.000 0.000 0.893
A vs. D 0.030 0.020 0.372 0.472 0.528
B vs. C 0.000 0.041 0.062 0.157 0.448
B vs. D 0.042 0.003 0.000 0.000 0.895
C vs. D 0.000 0.000 0.000 0.001 0.375
SBP: Systolic blood pressure, DBP: Diastolic blood pressure, WC: Waist circumference, BMI: Basal metabolic index, SD: Standard deviation
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are not controlled on time. Increased morbidity and mortality rate 
as a result of increase in cardiovascular diseases have been grossly 
reported in developing countries including Nigeria [27,28]. This may 
be attributed to the westernized lifestyle and physical inactivity among 
these participants [18,29]. The westernized lifestyle is as a result of 
frequent consumption of saturated fats, poor and unhealthy fast foods 
such as snacks, and indomie by university students. High incidence 
of overweight and obesity among female undergraduate students has 
been widely reported [25,30-32]. Our study has shown the presence of 
higher prevalence rate of central obesity in overweight as well as obese 
participants. This is consistent with the study reported by Ogunmola 
et al. [33] and Adegoke et al. [34]. The authors reported that in addition to 
unhealthy eating and physical inactivity, urbanization was also a factor. 
Excessive consumption of high calorie carbohydrate junk food [1,3] and 
saturated unprocessed palm fruit soup popularly known as “OfeAkwu” 
which is common and frequently consumed by students in this locality 
may also contribute greatly to the increase and accumulation of high 
amount of calorie and can result to the condition observed in this study. 
Reports have shown that central obesity is associated with cancer, heart 
diseases as well as lipid dysregulation and these can greatly contribute 
to risk of cardiovascular disorders [35,36]. The significant elevation in 
blood pressure among overweight and obese participants in this study 
suggests that these students might be predisposed to hypertension if 
appropriate intervention is not instituted. Previous reports have been 
documented [37,38]. There have been strong reports on significant 
association between obesity and hypertension in young adults [39-41]. 
It has also been established that lipid abnormality even in apparently 
normal subjects might result to hypertension [42].
The present study showed that TC, LDL, and FBG were significantly higher 
in overweight and obese participants when compared with normal 
participants. However, no significant difference was observed in TG level 
between the obese and control counterparts. High levels of fats and TC 
are potential risk factors for developing macrovascular complications 
such as coronary heart disease (CHD) and stroke [21,43-45]. Serum 
TC ranging from 5.0 to 6.5 mmol/L has been established as risk factor 
for CHD and considered undesirable [46]. Obesity is the leading cause 
of dyslipidemia (abnormal lipid concentrations) and diabetes mellitus. 
Dyslipidemia, on the other hand, has been associated with CHD which 
can be caused by elevated levels of TGs, TC, and LDLC [47].
Normal LDLC concentration has been established to be <130 mg/dl 
(3.36 mmol/L). Concentrations higher than 160 mg/dl (4.14 mmol/L) 
are considered high risk [47]. The findings in the present study 
showed that the obese participants were at high risk of developing 
cardiovascular disease which may be as result of oxidative modification 
of LDLC or other environmental factors such as lack of exercise and 
increased intake of junk foods with poor nutrients. Previous reports 
have shown that high levels of LDLC are an indication of progression to 
atherosclerosis which is a known risk of cardiovascular disorders, thus 
the major causes of morbidity and mortality [48].
Our study observed significantly lower level of HDL in obese subjects 
when compared with the value control participants. This is in 
agreement with the findings by Després [49] and Kimberly et al. [50]. 
Abnormal HDLC might be a leading cause of atherogenic dyslipidemia. 
Furthermore, the previous report has shown that a low level of high-
density lipoprotein cholesterol is consistent with atherosclerosis [51]. 
Furthermore, low HDL levels in obese subjects can contribute 
greatly to the risk of cardiovascular diseases. HDL is known as the 
“good cholesterol” which helps to mop up cholesterol, removes extra 
cholesterol from the peripheral tissues, and transports it to the liver 
for degradation and storage [51]. HDLC possesses a potent anti-
inflammatory and antioxidant effects which can prevent the atherogenic 
process [52,53].
The significantly higher FBG level observed in overweight and obese 
participants in the present study is consistent with the study done 
by McGill et al. [54] even though the increase was not higher than the 
reference range. The authors reported that obese subjects with elevated 
FBG are prone to diabetes mellitus. Individuals with FBG ranging from 
110 to 125 mg/dl have been postulated to have a double to 6-fold 
increase of developing diabetes mellitus [55]. These participants if 
the risk factors of obesity are not controlled may be predisposed to 
diabetes. Studies in Nigeria have documented the high incidence of 
impaired fasting glucose as well as impaired glucose tolerance [56-58]. 
Elevated glucose levels in the intermediate range are caused primarily 
by a deficiency in insulin secreted by pancreatic beta cells. Deficient 
insulin secretion can be caused by loss of beta cells or defect in the 
function of beta cell [59,60].
Table 3: Mean (±SD) levels of lipid profile (mmol/l) and FBG (mmol/l) in underweight, overweight, obese, and control female 
premedical students
Groups TC HDL LDL TG FBG
Underweight (A) (n=30) 4.05±0.25 1.46±0.43 3.01 ± 0.31 1.11±0.45 4.72±0.36
Overweight (B) (n=104) 5.28±0.86 1.07±0.29 3.46 ± 0.58 1.21±0.64 5.01±0.29
Obese (C) (n=31) 5.86±0.92 0.89±0.17 4.26 ± 0.84 1.25±0.84 5.12±0.38
Normotensive (D) (n=155) 4.41±0.84 1.44±0.56 3.18 ± 0.49 1.19±0.39 4.83±0.32
F-value 0.395 0.446 0.341 0.058 0.059
p-value 0.007 0.002 0.000 0.106 0.010 
A vs. B 0.000 0.000 0.000 0.863 0.029
A vs. C 0.000 0.000 0.000 0.581 0.000
A vs. D 0.063 0.873 0.811 0.360 0.741
B vs. C 0.046 0.058 0.000 0.673 0.692
B vs. D 0.000 0.003 0.010 0.773 0.000
C vs. D 0.001 0.000 0.000 0.315 0.006
TC: Total cholesterol, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, TG: Triglycerides, FBG: Fasting blood glucose, SD: Standard deviation
Table 4: Correlation of lipid profile (mmol/l), FBG (mmol/l), 
and anthropometric indices in overweight and obese female 
subjects
Parameters Overweight R Obese R p‑value
TC vs. BMI −0.353 −0.256 <0.005
TC vs. age 0.453 0.589 <0.005
TC vs. SBP −0.311 − 0.456 <0.005
TC vs. DBP −0.401 −0.442 <0.005
TC vs. FBG 0.383 0.399 <0.005
TG vs. BMI −0.438 −0.438 <0.005
TG vs. FBS 0.428 0.297 <0.005
TG vs. age 0.399 0.382 <0.005
TG vs. WC 0.275 0.288 <0.005
LDL vs. FBG 0.311 0.344 <0.005
HDL vs. BMI −0.714 −0.789 <0.005
HDL` vs. age 0.663 0.796 <0.005
HDL vs. WC −0.221 −0.256 <0.005
TC: Total cholesterol, HDL: High-density lipoprotein, LDL: Low-density 
lipoprotein, TG: Triglycerides, SBP: Systolic blood pressure, DBP: Diastolic blood 
pressure, WC: Waist circumference, BMI: Basal metabolic index, FBG: Fasting 
blood glucose
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An elevated glucose level is one major characteristic that can define 
metabolic syndrome. Others are abdominal obesity, elevated blood 
pressure, elevated TGs, and reduced HDL cholesterol. Any 3 of these 
5 conditions can establish the diagnosis of the syndrome [61,62]. 
However, the obese students, in this study, presented with similar 
findings showing possible development to pre-diabetes as well as 
metabolic syndrome if the obesity is not checked. Significant number of 
individuals with metabolic syndrome has abdominal obesity. Increased 
storage of fatty acids in the adipose tissue can lead to excessive release 
of adipokines. This can encourage metabolic susceptibility to diabetes 
and cardiovascular disease [63].
Significant positive correlation were observed between TC, HDL, TG 
and age, FBG while significant negative correlation existed between 
TC, HDL, TG and BMI, SBP DBP, WC respectively in overweight and 
obese participants. Similar reports have been previously documented 
[45,54,64-66]. Evidence has also shown that FBG positively correlated 
with BMI [67]. Adequate physical exercise increases the activation of 
the peptide hormone adiponectin that causes the cascade activation of 
activated protein kinase to prevent the syntheses of malonyl-coenzyme A 
(CoA) for fatty acid biosynthesis in hepatocytes by acetyl CoA carboxylase 
[67]. This enhances the uptake of glucose and fatty acid from the blood 
myocytes into the hepatocytes for metabolism [68,69]. The increased 
accumulation of weight by the female in the present study may also be 
attributed to creeping weight normally accumulated after sensitization 
of ghrelin hormone which enhances the hunger reflexes in females after 
strenuous activities. Females tend to relax after dietary intake, thereby 
resulting to increase in weight gain [70]. The significant association 
between lipid parameters and anthropometric indices in the present 
study might be attributed to risk factors for dyslipidemia, hypertension, 
and obesity [71]. Previous reports have shown that lipid abnormality 
even in normal subjects might result to hypertension and can enhance 
the risk of developing macrovascular complications [42,72]. Abnormal 
HDLC can result in endothelial damage and trigger an increase in BP; this 
might significantly contribute to CHD. Report has shown that low HDLC 
level of 1mg/dL (0.03 mmol/L) can result to risk of CHD in both men 
and women. Therefore, a low HDLC level of ≤40mg/dL (≤1.04 mmol/L) 
was established as undesirable for both genders [73,74] and should be 
regarded as a baseline for treatment to reduce cardiovascular risk.
CONCLUSION
The present study showed significantly higher levels of TC, LDLC, and 
FBG in overweight and obese female participants with significantly 
lower HDLC when compared to controls. The lipid parameters were 
significantly correlated with the anthropometric indices, suggesting 
that the study participants have high potentials for developing 
cardiovascular risk factors such as dyslipidemia, hypertension, and 
obesity. However, this study justifies the need to encourage modalities 
and appropriate interventions to promote healthy body mass, frequent 
physical activities, and high calorie dietary controls with quality 
protein foods and fruits to prevent or minimize risks of developing 
disorders associated with obesity among the study population. A more 
longitudinal study is also advocated in the study environment, male 
student inclusive, to ascertain a clearer picture of overweight and 
obesity status among these individuals to cub the increase and future 
menace of cardiovascular disease among this young population.
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